Cognition Therapeutics In... (CGTX)
NASDAQ: CGTX
· Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT
Cognition Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.73M | -8.48M | -7.84M | -9.94M | -7.04M | -9.15M | -8.14M | -6.75M | -4.73M | -6.17M | -5.18M | -6.63M | -5.75M | -3.84M | -7.34M | -3.11M | -1.49M | 223K |
Depreciation & Amortization | 61K | 45K | 71K | 70K | 67K | 58K | 66K | 65K | 61K | 60K | 60K | 60K | 59K | 56K | 23K | 23K | 24K | 23K |
Stock-Based Compensation | 621K | 586K | 534K | 896K | 1.15M | 1.17M | 1.07M | 1.07M | 1.02M | 1.19M | 902K | 777K | 892K | 1M | 4.92M | 72K | 94K | 98K |
Other Working Capital | 1.32M | 139K | -1.83M | -2.15M | 343K | 440K | 1.2M | 1.45M | -56K | 1.98M | -953K | 1M | -207K | -36K | -205K | 731K | 996K | -845K |
Other Non-Cash Items | n/a | n/a | n/a | 1.97M | n/a | 195K | 841K | 5K | 691K | 318K | -943K | -4.65M | -616K | 1.81M | -1.07M | 932K | 101K | 282K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -846K | n/a | -691K | n/a | 943K | 4.65M | n/a | n/a | 1.33M | n/a | -102K | -1.51M |
Change in Working Capital | 429K | -2.03M | -1.15M | 154K | -170K | 483K | 1.55M | 1.45M | -56K | 1.9M | -5.96M | 5.78M | -556K | -207K | 2.24M | 33K | 463K | 108K |
Operating Cash Flow | -5.62M | -9.88M | -8.38M | -6.85M | -6M | -7.24M | -5.46M | -4.16M | -3.7M | -2.71M | -10.18M | -4K | -5.36M | -2.99M | 101K | -2.05M | -910K | -772K |
Capital Expenditures | n/a | n/a | -1K | 3K | -3K | n/a | -30K | -58K | -18K | -41K | -10K | -23K | -4K | -134K | -27K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -3K | n/a | n/a | n/a | n/a | n/a | n/a | -171K | n/a | n/a | -134K | -27K | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -1K | n/a | -3K | n/a | -30K | -58K | -18K | -41K | -10K | -23K | -4K | -134K | -27K | n/a | n/a | n/a |
Debt Repayment | -120K | -118K | -195K | -185K | -181K | -178K | -179K | -215K | -210K | -207K | -205K | -401K | -396K | -394K | -268K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5K | -46K | n/a | 17K | -22K | -106K | n/a | n/a | n/a | n/a | 5.35M | 1.27M | 22K | 303K | 46.63M | -961K | -1.16M | 8.96M |
Financial Cash Flow | 752K | 1.3M | 11.38M | 329K | -138K | 11.99M | 2.44M | -3K | 2.1M | -10K | 5.14M | 869K | -374K | -91K | 46.36M | -961K | -1.16M | 8.96M |
Net Cash Flow | -4.87M | -8.58M | 3M | -6.52M | -6.14M | 4.75M | -3.05M | -4.22M | -1.62M | -2.75M | -5.05M | 839K | -5.74M | -3.21M | 46.41M | -2.99M | -2.07M | 8.18M |
Free Cash Flow | -5.62M | -9.88M | -8.38M | -6.85M | -6M | -7.24M | -5.49M | -4.22M | -3.71M | -2.75M | -10.19M | -27K | -5.36M | -3.12M | 74K | -2.05M | -910K | -772K |